Xbiotech Inc share price logo

Xbiotech Inc Share Price

NASDAQ: XBIT

Small Cap

$2.77

-0.04

(-1.60%)

as on

Xbiotech Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $2.76
    $2.86
    downward going graph

    0.36%

    Downside

    3.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.5
    $8.32
    downward going graph

    9.75%

    Downside

    200.36%

    Upside

    downward going graph

Xbiotech Inc share price movements today

Previous Close
$2.82
Open
$2.84
Volume
373.5K
Day's Low - High
$2.76 - $2.86
52 Week Low - High
$2.5 - $8.32

Xbiotech Inc Historical Returns

1 Month Return
-12.42 %
3 Month Return
+ 4.17 %
1 Year Return
-61.05 %
3 Year Return
-32.27 %
5 Year Return
-85.52 %

Xbiotech Inc Stock Fundamentals & Key Indicators

Check Xbiotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$86.0M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-9.16

Industry PE ratio

-3.773885542168675

P/B Ratio

0

PEG Ratio

0

EBITDA

-34.8M

Revenue (TTM)

300.0K

Profit Margin

0.00%

Return On Equity TTM

0.00%

Xbiotech Inc Stock Valuation

Track how Xbiotech Inc P/E has moved over time to understand its valuation trends.

Xbiotech Inc in the last 5 years

  • Overview

  • Trends

Lowest (1.19x)

September 30, 2020

Today (-9.16x)

September 13, 2025

Industry (-3.77x)

September 13, 2025

Highest (1.19x)

September 30, 2020

LowHigh

Today’s Price to Earnings Ratio: -9.16x

Xbiotech Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xbiotech Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$86.0M-85.52%-9.160.00%
BUY$61.1B280.5%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.2B54.04%28.0831.86%
BUY$59.4B2.03%14.1131.37%

Stock Returns calculator for Xbiotech Inc Stock including INR - Dollar returns

The Xbiotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xbiotech Inc investment value today

Current value as on today

₹44,374

Returns

₹55,626

(-55.63%)

Returns from Xbiotech Inc Stock

₹60,765 (-60.76%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Xbiotech Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xbiotech Inc. Average target price of $18

Xbiotech Inc Share Price Target

Get share price movements and forecasts by analysts on Xbiotech Inc.

What analysts predicted

84.61%UPSIDE

Target Price

$18

Current Price

$2.77

Analyzed by

7 Analysts

Target

$18.00

Xbiotech Inc target price $18, a slight upside of 84.61% compared to current price of $2.77. According to 7 analysts rating.

Xbiotech Inc Stock's Interest Amongst Investors

Search interest for Xbiotech Inc Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-39% versus previous 30 day period

Xbiotech Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
2
2
-
-
-
0
-
Gross Profit
0
0
0
2
2
0
0
-
0
0
Operating Income
-7
-13
-8
-8
-10
-14
-7
-8
-13
-6
EBITDA
-6
-12
-8
-8
-10
-14
-4
-9
-10
-1
Interest Expense
3
-
-
3
3
0
0
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-8
-7
-4
-9
-13
-5
-10
-10
-1
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
-8
-7
-4
-10
-13
-5
-10
-10
-1
Net Profit Margin
0.00%
0.00%
0.00%
-176.91%
-381.76%
0.00%
0.00%
0.00%
-1255.36%
0.00%

Xbiotech Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
12
43
18
4
0
-
Gross Profit
0
0
-
-2
-2
9
12
3
-1
-
Operating Income
-37
-52
-34
-20
-31
-18
-25
-34
-37
-42
EBITDA
-36
-52
-33
-18
-28
-16
-22
-31
-35
-36
Interest Expense
-
-
-
-
748
8
1
0
-
0
Depreciation
-
-
1
2
2
2
2
2
1
1
Income Before Tax
-37
-52
-33
-21
718
-12
-25
-33
-24
-38
Income Tax Expense
0
0
0
0
49
-1
-8
0
0
0
Net Income
-37
-52
-33
-21
668
-11
-17
-32
-24
-38
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
5272.68%
-25.50%
-94.67%
-820.45%
-8185.67%
0.00%

Xbiotech Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-8
-7
-4
-10
-13
-5
-10
-10
-1
Operating Cash Flow
-8
-1
-3
-7
-11
-5
-6
-6
-5
Investing Cash Flow
0
61
-
0
0
0
-
0
0
Financing Cash Flow
9
0
-9
10
0
0
0
-10
-
Change in Cash
-9
58
-2
1
-12
-5
-10
-16
-2

Xbiotech Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-52
-33
-21
668
-11
-17
-32
-24
-38
Operating Cash Flow
-46
-33
-16
-18
-65
69
-14
-18
-30
Investing Cash Flow
-13
-1
0
674
-3
-3
-63
61
-1
Financing Cash Flow
2
33
0
42
-409
-67
0
0
10
Change in Cash
-56
-2
-15
698
-477
0
-79
42
-27

Global Institutional Holdings in Xbiotech Inc

Funds
Holdings
BlackRock Inc
4.22%
Vanguard Group Inc
3.49%
Geode Capital Management, LLC
1.51%
State Street Corp
0.75%
Northern Trust Corp
0.69%

Insights on Xbiotech Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -10.88M → -1.75M (in $), with an average increase of 519.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 136.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 153.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, XBIT stock has moved down by -14.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 2.62M → 867.0K (in $), with an average decrease of 66.9% per quarter

About Xbiotech Inc

xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..
OrganisationXbiotech Inc
Headquarters5217 Winnebago Lane, Austin, TX, United States, 78744
IndustryHealth Technology
CEOMr. John Simard
E-voting on sharesClick here to vote

Key Management of Xbiotech Inc

Name

Title

Ms. Angela Hu

Director of Finance

Dr. Sushma Shivaswamy Ph.D.

Chief Scientific Officer

Mr. John Simard

Founder, President, CEO & Chairman

FAQs

What is Xbiotech Inc share price today?

Xbiotech Inc share price today is $2.77 as on at the close of the market. Xbiotech Inc share today touched a day high of $2.86 and a low of $2.76.

What is the 52 week high and 52 week low for Xbiotech Inc share?

Xbiotech Inc share touched a 52 week high of $8.32 on and a 52 week low of $2.5 on . Xbiotech Inc stock price today i.e. is closed at $2.77,which is 66.71% down from its 52 week high and 10.80% up from its 52 week low.

What is Xbiotech Inc's market capitalisation today?

Xbiotech Inc market capitalisation is $0.00T as on .

How to invest in Xbiotech Inc Stock (XBIT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xbiotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xbiotech Inc Shares that will get you 0.5415 shares as per Xbiotech Inc share price of $2.77 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xbiotech Inc Stock (XBIT) from India?

Indian investors can start investing in Xbiotech Inc (XBIT) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Xbiotech Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xbiotech Inc share’s latest price of $2.77 as on September 13, 2025 at 1:29 am IST, you will get 3.6101 shares of Xbiotech Inc. Learn more about fractional shares .

What are the returns that Xbiotech Inc has given to Indian investors in the last 5 years?

Xbiotech Inc stock has given -85.52% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?